Cassava Sciences

Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease
Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease
BioSpace
Cassava Sciences
clinical trials
Simulfilam
Alzheimer's disease
Flag link:
Why Shares of Cassava Sciences Are Dropping Wednesday
Why Shares of Cassava Sciences Are Dropping Wednesday
Motley Fool
Cassava Sciences
simufilam
Alzheimer's disease
Flag link:
Why Shares of Cassava Sciences Jumped Last Week
Why Shares of Cassava Sciences Jumped Last Week
Motley Fool
Cassava Sciences
Simulfilam
oncology
cancer
Flag link:
Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease
Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease
BioSpace
Cassava Sciences
clinical trials
simufilam
Alzheimer's disease
Flag link:
Roche Failure Leaves Industry Reassessing Alzheimer's Space
Roche Failure Leaves Industry Reassessing Alzheimer's Space
BioSpace
Roche
Alzheimer's disease
gantenerumab
Biogen
Cassava Sciences
Eli Lilly
Flag link:
No Evidence of Data Manipulation in Science Publication on Simufilam
No Evidence of Data Manipulation in Science Publication on Simufilam
BioSpace
Cassava Sciences
Alzhimer's disease
Simulfilam
data manipulation
Flag link:
Cassava Sciences faces U.S. criminal probe tied to Alzheimer's drug, sources say
Cassava Sciences faces U.S. criminal probe tied to Alzheimer's drug, sources say
Reuters
Cassava Sciences
DOJ
data manipulation
Alzheimer's disease
simufilam
Flag link:
Life Sciences Industry has Eyes on Texas' Innovation Corridor
Life Sciences Industry has Eyes on Texas' Innovation Corridor
BioSpace
Texas
biotech hubs
life sciences
Fujifilm
BioBridge
Luminex
Vaxxinity
Veravas
Cassava Sciences
Flag link:
Cassava Faces Renewed Speculation Over Experimental Alzheimer’s Drug
Cassava Faces Renewed Speculation Over Experimental Alzheimer’s Drug
BioSpace
Cassava Sciences
Alzheimer's disease
simufilam
Flag link:
Cassava 10K Filing Warns of Anticipated Hold, Paints Dire Picture of Alzheimer's Space
Cassava 10K Filing Warns of Anticipated Hold, Paints Dire Picture of Alzheimer's Space
BioSpace
Cassava Sciences
FDA
clinical trials
Alzheimer's disease
simufilam
Flag link:
Cassava scores a win as FDA declines to intervene in petition to stop its Alzheimer's drug trials
Cassava scores a win as FDA declines to intervene in petition to stop its Alzheimer's drug trials
Fierce Biotech
Cassava Sciences
FDA
clinical trials
Alzheimer's disease
simufilam
Flag link:
Where Will Cassava Sciences Be in 1 Year?
Where Will Cassava Sciences Be in 1 Year?
Motley Fool
Cassava Sciences
Simulfilam
clinical trials
Alzheimer's disease
Flag link:
Cassava Sciences under SEC probe for manipulating Alzheimer’s drug data
Cassava Sciences under SEC probe for manipulating Alzheimer’s drug data
Seeking Alpha
Cassava Sciences
SEC
data manipulation
Alzheimer's disease
Flag link:
Is Cassava Sciences Back in the Game?
Is Cassava Sciences Back in the Game?
Motley Fool
FDA
Cassava Sciences
simufilam
Alzheimer's disease
Flag link:
Why Shares of Cassava Sciences Rose 15% Today
Why Shares of Cassava Sciences Rose 15% Today
Motley Fool
Cassava Sciences
Alzheimer's disease
simufilam
NIH
Flag link:
Cassava CEO, ‘dazed and confused’, takes to biotech defense handbook by blaming short sellers for woes
Cassava CEO, ‘dazed and confused’, takes to biotech defense handbook by blaming short sellers for woes
Fierce Biotech
Cassava Sciences
FDA
Alzheimer's disease
Flag link:
Cassava's stock tumbles again, after Quanterix said it 'did not' prepare data charts presented by Cassava, that are under dispute
Cassava's stock tumbles again, after Quanterix said it 'did not' prepare data charts presented by Cassava, that are under dispute
Marketwatch
Quanterix
Cassava Sciences
Alzheimer's disease
Flag link:
Here's Why Cassava Sciences Is Having a Bad Day
Here's Why Cassava Sciences Is Having a Bad Day
Motley Fool
Cassava Sciences
FDA
citizen petitions
simufilam
Flag link:
Here's What Investors Should Know About Cassava's Alzheimer's Drug Candidate
Here's What Investors Should Know About Cassava's Alzheimer's Drug Candidate
Motley Fool
Cassava Sciences
Alzheimer's disease
simufilam
Flag link:
Biden's Budget May Boost These 3 Biotechs
Biden's Budget May Boost These 3 Biotechs
Motley Fool
Joe Biden
Alzheimer's disease
Denali Therapeutics
Cassava Sciences
Eli Lilly
Flag link:

Pages